Medical Condition News

RSS

UAB first hospital in Alabama to offer Melody Valve replacement

In many ways Dylan Fields is your typical 15-year-old boy. He loves sports, and plays baseball and soccer for his school, Tallassee High, in Central Alabama. What's not typical about Dylan is his heart defect and, now, the procedure used to repair his heart.

6 Mar 2012

Viewpoints: Statins and diabetes; Frightening tobacco warnings; The U.S. dental crisis

We're overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes. This past week, the Food and Drug Administration raised questions about the side effects of these drugs and developed new labels for these medications that will now warn of the risk of diabetes and memory loss.

6 Mar 2012

New AD marker can predict mental decline

A new marker of Alzheimer's disease can predict how rapidly a patient's memory and other mental abilities will decline after the disorder is diagnosed, researchers at Washington University School of Medicine in St. Louis have found.

6 Mar 2012

Almost 70% of young adults with Asperger syndrome have suffered from depression

Given that almost 70% of young adults with Asperger syndrome have suffered from depression, it is vital that psychiatric care staff are aware of this so that patients are given the right treatment, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

6 Mar 2012

Cenderitide may preserve cardiac function after heart attack

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), has awarded a $2.5 million grant to Mayo Clinic's Cardiorenal Research Laboratory to conduct a highly innovative research project, "Cardiovascular Peptides and Myocardial Infarction."

6 Mar 2012

Study shows how new information is encoded into prefrontal cortex

The brain has a remarkable ability to learn new cognitive tasks while maintaining previously acquired knowledge about various functions necessary for everyday life. But exactly how new information is incorporated into brain systems that control cognitive functions has remained a mystery.

6 Mar 2012

HGVs pose increased risk of death and serious injury to cyclists

A study by researchers at Queen Mary, University of London and Barts and The London NHS Trust proves that HGVs pose the greatest risk of death and serious injury to cyclists.

6 Mar 2012

Penn-led team develops universal approach to personalized cancer therapy based on T cells

Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells. It is the first time a system for making an adaptable, engineered T-cell to attack specific tumor types has been proposed, depending on which abnormal proteins, called antigens, are expressed by individual patients' tumor cells.

6 Mar 2012

Neuroimaging for stroke patients may be unnecessarily costly and redundant

Neuroimaging for stroke patients may be unnecessarily costly and redundant, contributing to rising costs nationwide for stroke care, according to University of Michigan research.

6 Mar 2012

Gamma Knife vs. craniotomy to treat epilepsy

For about 25 percent of patients suffering from epilepsy, medications do not effectively control the disease and stop seizures. For some, epilepsy surgery is the best answer. In the past, epilepsy surgery meant a craniotomy, which requires a surgeon to open the patient's skull to remove the brain lesion causing epilepsy.

6 Mar 2012

Prazosin drug shows promise against PTSD-related nightmares

Mayo Clinic researchers this week will announce the use of the blood pressure drug prazosin as an effective treatment to curb post- traumatic stress disorder (PTSD)-related nightmares.

6 Mar 2012

EntreMed plans to establish drug development office in China

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has initiated plans to establish an office in China to facilitate the Company's drug development and clinical trials in that country.

6 Mar 2012

Merck announces results from AIT Phase III clinical study for ragweed allergy

Merck, known as MSD outside the United States and Canada, today announced the results from a Phase III clinical study of its investigational allergy immunotherapy tablet (AIT) for ragweed pollen.

6 Mar 2012

Mayo Clinic experts available to discuss latest colorectal cancer research and treatment

March is National Colorectal Cancer Awareness Month. Colon cancer is one of the most common and deadly cancers, and also one of the most preventable. Mayo Clinic experts are available to discuss the latest in colorectal cancer research, detection and treatment.

6 Mar 2012

Persistent protein expression may explain why tumors return after therapy in glioblastoma patients

Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published on March 5th in the Journal of Experimental Medicine.

6 Mar 2012

New DNA-reading technology could lead to correct genetic diagnosis for muscle-wasting diseases

Scientists at The University of Nottingham have used a revolutionary new DNA-reading technology for a research project that could lead to correct genetic diagnosis for muscle-wasting diseases.

6 Mar 2012

Scientists identify novel protein expressed by breast cancer cells

A team of scientists at the University of California, San Diego Moores Cancer Center has identified a novel protein expressed by breast cancer cells - but not normal adult tissues - that could provide a new target for future anti-cancer drugs and treatments.

6 Mar 2012

Scientists to investigate biochemical switch: P2X1 receptor

Scientists investigating a 'biochemical switch' linked to strokes and heart disease claim to have made an advance in understanding how it is 'turned on'.

6 Mar 2012

$Millennium commences MLN8237 phase 3 trial in relapsed or refractory PTCL$

Millennium commences MLN8237 phase 3 trial in relapsed or refractory PTCL

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the initiation of an international phase 3 clinical trial evaluating MLN8237 in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), an aggressive form of lymphoma.

5 Mar 2012

Scientists identify gene that causes adult-onset primary cervical dystonia

Researchers have identified a gene that causes adult-onset primary cervical dystonia, an often-painful condition in which patients' necks twist involuntarily.

5 Mar 2012